Targeted Drug Delivery for Chronic Nonmalignant Pain: Longitudinal Data From the Product Surveillance Registry.

ABSTRACT:

Objectives

To assist in assessment of therapy risks and benefits of targeted drug delivery (TDD) for chronic nonmalignant pain using registry data on product performance, adverse events, and elective device replacement.

Materials and methods

The Product Surveillance Registry (PSR) (NCT01524276) is an ongoing prospective, long-term, multicenter registry enrolling consented patients implanted with an intrathecal drug delivery system. Patients are followed prospectively with participating investigators providing pump and catheter performance data for events related to the device, procedure, and therapy. Event descriptions include patient symptoms and outcomes.

Results

Registry data from the 4646 patients (59.7% female) treated with TDD for chronic, nonmalignant pain at 5

SUBMITTER: Schultz DM 

PROVIDER: S-EPMC8597001 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature